Pro Share Advisors LLC Precision Biosciences Inc Transaction History

Pro Share Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$1.15 - $3.34 $18,128 - $52,651	-15,764 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$2.96 - $7.76 $11,348 - $29,751	-3,834 Reduced 19.56%	15,764 $48,000
Q4 2021 Feb 08, 2022	BUY	$7.4 - $11.66 $3,848 - $6,063	520 Added 2.73%	19,598 $144,000
Q3 2021 Nov 12, 2021	SELL	$9.18 - $14.15 $32,864 - $50,657	-3,580 Reduced 15.8%	19,078 $220,000
Q2 2021 Aug 13, 2021	BUY	$8.07 - $12.52 $23,992 - $37,221	2,973 Added 15.1%	22,658 $284,000
Q1 2021 May 14, 2021	BUY	$8.57 - $15.79 $10,986 - $20,242	1,282 Added 6.97%	19,685 $204,000
Q4 2020 Feb 09, 2021	BUY	$5.98 - $12.47 $25,528 - $53,234	4,269 Added 30.2%	18,403 $153,000
Q3 2020 Nov 13, 2020	SELL	$4.65 - $8.73 $1,655 - $3,107	-356 Reduced 2.46%	14,134 $87,000
Q2 2020 Aug 03, 2020	BUY	$4.66 - $8.7 $67,523 - $126,062	14,490 New	14,490 $121,000
Q1 2020 May 15, 2020	SELL	$5.05 - $15.01 $80,057 - $237,953	-15,853 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$6.32 - $19.66 $100,190 - $311,669	15,853 New	15,853 $220,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $791M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.